Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History MNMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics MNMD

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Mind Medicine Inc

MNMD
Current price
8.88 USD -0.07 USD (-0.78%)
Last closed 8.58 USD
ISIN CA60255C8850
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 648 247 296 USD
Yield for 12 month +11.98 %
1Y
3Y
5Y
10Y
15Y
MNMD
21.11.2021 - 28.11.2021

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York. Address: One World Trade Center, New York, NY, United States, 10007

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

24.50 USD

P/E Ratio

Dividend Yield

Financials MNMD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures MNMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-3 162 000 USD

Current Quarter

Last Quarter

EBITDA -114 364 248 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -25.84 %
PEG Ratio
Return On Equity TTM -37.07 %
Wall Street Target Price 24.50 USD
Revenue TTM
Book Value 2.95 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.75 USD
Diluted Eps TTM -0.75 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation MNMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -6.57
Price Book MRQ 2.82

Technical Indicators MNMD

For 52 Weeks

4.70 USD 10.44 USD
50 Day MA 7.10 USD
Shares Short Prior Month 11 065 859
200 Day MA 6.88 USD
Short Ratio 9.07
Shares Short 11 165 609
Short Percent 14.76 %